Clinical Trials Browser

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT02908048 2025-04-06

Extracellular RNA Markers of Liver Disease and Cancer

Active not recruiting

1,810 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT06707025 2025-03-14

CD24CCA

Active not recruiting

50 enrolled

Gastrointestinal

Liver Neoplasms, Cholangiocarcinoma

NCT06703853 2024-11-25

cfDNA

Active not recruiting

1,000 enrolled

Gastrointestinal

Liver Neoplasms, Neoplasms

NCT06315361 2024-03-18

DIANA

Active not recruiting

600 enrolled

Gastrointestinal

Diabetes Mellitus, Fibrosis, Liver Cirrhosis, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT03347162 2023-06-22

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

Active not recruiting

1,000 enrolled

Gastrointestinal

Esophageal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Clinical Trials

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

Precision1

DTECT-Liver

The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma

Tempus Priority Study: A Pan-tumor Observational Study

Extracellular RNA Markers of Liver Disease and Cancer

CD24CCA

cfDNA

DIANA

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer